CompletedNot Applicable

Effect of Ocrelizumab on Choroid Plexus Changes in Patients With PPMS

United States732 participantsStarted 2023-10-01

Plain-language summary

The goal of this non-interventional, observational study is to learn if cortical plexus enhancement in patients with primary progressive multiple sclerosis occurs in response to the autoimmune inflammatory process.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient participating in the ORATORIO study * MRI scans available at baseline * Presence of T2-weighted image (WI) (FLAIR, T2/PD), and 3D T1-WI at baseline Exclusion Criteria: \- None

What they're measuring

T2 lesion volume

Timeframe: 5 years

Trial details

NCT IDNCT05974852

SponsorState University of New York at Buffalo

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-30

View on ClinicalTrials.gov More Primary Progressive Multiple Sclerosis trials